Table of Contents

company-logo

Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule superoxide dismutase mimetic, which has completed Phase III clinical trial for the treatment of radiotherapy induced severe oral mucositis in patients with head and neck cancer (HNC); in Phase IIa clinical trial for the treatment of radiotherapy-induced esophagitis in patients with lung cancer; and in Phase IIa clinical trial for patients with HNC undergoing standard-of-care radiotherapy. It is also involved in developing GC4711, a superoxide dismutase mimetic product candidate, which is in Phase I/II clinical trial in combination with stereotactic body radiation therapy (SBRT) in patients with non-small cell lung cancer and locally advanced pancreatic cancer. The company was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.

Galera Therapeutics Dividend Announcement

• Galera Therapeutics does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Galera Therapeutics dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Galera Therapeutics Dividend History

Galera Therapeutics Dividend Yield

Galera Therapeutics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Galera Therapeutics stock? Use our calculator to estimate your expected dividend yield:

Galera Therapeutics Financial Ratios

P/E ratio-0.06
PEG ratio0.09
P/B ratio-0.01
ROE21.95%
Payout ratio0.00%
Current ratio5.63
Quick ratio5.63
Cash Ratio5.06

Galera Therapeutics Dividend FAQ

Does Galera Therapeutics stock pay dividends?
Galera Therapeutics does not currently pay dividends to its shareholders.
Has Galera Therapeutics ever paid a dividend?
No, Galera Therapeutics has no a history of paying dividends to its shareholders. Galera Therapeutics is not known for its dividend payments.
Why doesn't Galera Therapeutics pay dividends?
There are several potential reasons why Galera Therapeutics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Galera Therapeutics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Galera Therapeutics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Galera Therapeutics a dividend aristocrat?
Galera Therapeutics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Galera Therapeutics a dividend king?
Galera Therapeutics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Galera Therapeutics a dividend stock?
No, Galera Therapeutics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Galera Therapeutics stocks?
To buy Galera Therapeutics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Galera Therapeutics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.